{
    "clinical_study": {
        "@rank": "142860", 
        "brief_summary": {
            "textblock": "To determine optimal cut-off value for TopQ cut-off."
        }, 
        "brief_title": "TopQ Cut-Off Determination Study", 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  No known ocular pathologies\n\n        Exclusion Criteria:\n\n          -  Any known ocular pathologies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Sujects that have no known ocular pathologies"
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824784", 
            "org_study_id": "DC-03273"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Normal Eyes", 
        "lastchanged_date": "January 22, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Oakland", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "07436"
                }, 
                "name": "Topcon Medical Systems, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "TopQ Cut-off Determination Study", 
        "overall_official": {
            "affiliation": "Director of Clinical Marketing", 
            "last_name": "Michael Sinai, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Retinal Thickness", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824784"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Topcon Medical Systems, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Topcon Medical Systems, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}